Arcutis Biotherapeutics (ARQT) Other Gross PP&E Adjustments (2020 - 2025)
Arcutis Biotherapeutics (ARQT) has 6 years of Other Gross PP&E Adjustments data on record, last reported at -$7.9 million in Q4 2025.
- For Q4 2025, Other Gross PP&E Adjustments rose 43.87% year-over-year to -$7.9 million; the TTM value through Dec 2025 reached -$7.9 million, up 43.87%, while the annual FY2025 figure was -$7.9 million, 43.87% up from the prior year.
- Other Gross PP&E Adjustments reached -$7.9 million in Q4 2025 per ARQT's latest filing, down from -$4.6 million in the prior quarter.
- Across five years, Other Gross PP&E Adjustments topped out at $818000.0 in Q3 2023 and bottomed at -$14.1 million in Q4 2024.
- Average Other Gross PP&E Adjustments over 5 years is -$2.9 million, with a median of -$1.8 million recorded in 2025.
- Peak YoY movement for Other Gross PP&E Adjustments: surged 1378.12% in 2023, then plummeted 1215.27% in 2024.
- A 5-year view of Other Gross PP&E Adjustments shows it stood at -$4.4 million in 2021, then tumbled by 71.6% to -$7.5 million in 2022, then dropped by 13.51% to -$8.5 million in 2023, then tumbled by 65.64% to -$14.1 million in 2024, then skyrocketed by 43.87% to -$7.9 million in 2025.
- Per Business Quant database, its latest 3 readings for Other Gross PP&E Adjustments were -$7.9 million in Q4 2025, -$4.6 million in Q3 2025, and -$1.7 million in Q2 2025.